Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 7


Pharmacological and behavioral characterization of D-473, an orally active triple reuptake inhibitor targeting dopamine, serotonin and norepinephrine transporters.

Dutta AK, Santra S, Sharma H, Voshavar C, Xu L, Mabrouk O, Antonio T, Reith ME.

PLoS One. 2014 Nov 26;9(11):e113420. doi: 10.1371/journal.pone.0113420. eCollection 2014.


Forebrain glucocorticoid receptor gene deletion attenuates behavioral changes and antidepressant responsiveness during chronic stress.

Jacobson L.

Brain Res. 2014 Oct 2;1583:109-21. doi: 10.1016/j.brainres.2014.07.054. Epub 2014 Aug 26.


Boosting serotonin in the brain: is it time to revamp the treatment of depression?

Torrente MP, Gelenberg AJ, Vrana KE.

J Psychopharmacol. 2012 May;26(5):629-35. doi: 10.1177/0269881111430744. Epub 2011 Dec 8.


Resting glutamate levels and rapid glutamate transients in the prefrontal cortex of the Flinders Sensitive Line rat: a genetic rodent model of depression.

Hascup KN, Hascup ER, Stephens ML, Glaser PE, Yoshitake T, Mathé AA, Gerhardt GA, Kehr J.

Neuropsychopharmacology. 2011 Jul;36(8):1769-77. doi: 10.1038/npp.2011.60. Epub 2011 Apr 27.


Linking molecules to mood: new insight into the biology of depression.

Krishnan V, Nestler EJ.

Am J Psychiatry. 2010 Nov;167(11):1305-20. doi: 10.1176/appi.ajp.2009.10030434. Epub 2010 Sep 15. Review.


Reconsidering anhedonia in depression: lessons from translational neuroscience.

Treadway MT, Zald DH.

Neurosci Biobehav Rev. 2011 Jan;35(3):537-55. doi: 10.1016/j.neubiorev.2010.06.006. Epub 2010 Jul 11. Review.

Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk